|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/423 | (2006.01) |
| C07D 263/57 | (2013.01) | ||
| C07D 263/57 | (2006.01) | ||
| A61K 31/423 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3977993 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21203965.5 |
| Date of filing the European patent application | 2015-08-31 | |
| (97) | Date of publication of the European application | 2022-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462047614 P | 2014-09-08 | US | |
| 201562203953 P | 2015-08-12 | US |
| (72) |
GIRARD, Kevin Paul , US
JENSEN, Andrew J. , US
JONES, Kris Nicole , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE FOR USE AS A MEDICAMENT |
| CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE FOR USE AS A MEDICAMENT |